Small Business Innovation Research and Small Business Technology Transfer Programs Phase I
ID: 355247Type: Posted
Overview

Buyer

National Institute of Food and Agriculture (USDA-NIFA)

Award Range

$125K - $182K

Eligible Applicants

Others

Funding Category

Agriculture

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355247

Additional Information

https://www.nifa.usda.gov/grants/funding-opportunities/small-business-innovation-research-small-business-technology-transfer
Timeline
    Description

    The National Institute of Food and Agriculture (NIFA) is inviting applications for its Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs Phase I for Fiscal Year 2025. This funding opportunity aims to support small businesses in developing innovative technologies with commercial potential across various topics, including forestry, aquaculture, food science, and rural development, while also promoting diversity, equity, inclusion, and accessibility in research participation. The total anticipated funding for this initiative is $15.5 million, with individual awards ranging from $125,000 to $181,500, and applications are due by September 17, 2024. Interested applicants can reach out to NIFA for guidance on topic suitability and must adhere to compliance measures regarding foreign partnerships as outlined in the SBIR and STTR Extension Act of 2022.

    Files
    Title
    Posted
    FY25-SBIR-STTR-Phase-1-RFA-P.pdf
    The USDA is inviting applications for the 2025 Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs Phase I, with a total funding of $15.5 million available. The application deadline is September 17, 2024, and eligible applicants, particularly from underserved communities, are encouraged to engage in diverse research areas including climate-smart agriculture, food science, and rural development. The program aims to support the commercialization of innovative technologies while fostering partnerships between small businesses and research institutions.
    Similar Opportunities
    Agriculture and Food Research Initiative Sustainable Agricultural Systems
    National Institute of Food and Agriculture
    The National Institute of Food and Agriculture (NIFA) is offering the Agriculture and Food Research Initiative (AFRI) Sustainable Agricultural Systems (SAS) grant for Fiscal Year 2025, with a total funding pool of $70 million. This initiative aims to support innovative projects that promote transformational changes in the U.S. food and agriculture system, focusing on climate-smart, sustainable, and accessible food systems while addressing challenges such as climate change and food security. Eligible applicants include colleges, universities, and minority-serving institutions, and projects must integrate research, education, and extension components with an emphasis on stakeholder engagement and equitable benefits for underserved communities. Interested parties should note that the application deadline is May 15, 2025, with an optional Notification of Intent due by March 27, 2025. For further details, applicants can contact NIFA at grantapplicationquestions@usda.gov.
    PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA), has announced the PHS 2024-2 Omnibus Solicitation for Small Business Innovation Research (SBIR) Grant Applications. This funding opportunity invites eligible U.S. small businesses to submit applications for Phase I, Phase II, Fast-Track, and Direct to Phase II projects that align with the research missions of the NIH, CDC, and FDA, with a focus on stimulating technological innovation and commercialization of federal R&D investments. Notably, applications must not include clinical trials, and funding levels are capped at $306,872 for Phase I and up to $2,045,816 for Phase II, with a submission deadline of April 5, 2025. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the PHS 2024-2 Omnibus Solicitation for Small Business Technology Transfer (STTR) Grant Applications, inviting eligible U.S. small businesses to submit proposals for innovative projects that align with NIH's research and development mission. This funding opportunity, identified as PA-24-247, specifically excludes clinical trials and aims to foster collaboration between small businesses and research institutions to advance technology development in health-related fields. Eligible applicants must be for-profit small businesses based in the U.S., with budget limits set at $306,872 for Phase I and $2,045,816 for Phase II awards. The application deadline is April 5, 2025, with an initial submission date of September 5, 2024. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the PHS 2024-2 Omnibus Solicitation for Small Business Technology Transfer (STTR) grant applications, inviting eligible U.S. small businesses to submit proposals that include at least one clinical trial. This funding opportunity aims to support research and development projects that align with the scientific missions of participating NIH Institutes and Centers, emphasizing the importance of innovation in health-related technologies. Eligible applicants must be U.S.-based small businesses with majority ownership by U.S. citizens or resident aliens, and the grants provide funding caps of up to $306,872 for Phase I and $2,045,816 for Phase II projects. Interested parties should note that the application deadline is April 5, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) have announced the PHS 2024-2 Omnibus Solicitation for Small Business Innovation Research (SBIR) grant applications, specifically requiring clinical trials. This funding opportunity is aimed at U.S. small businesses with the necessary research capabilities to contribute to the missions of the NIH and CDC, encouraging innovation and the commercial viability of health technologies. Eligible applicants can receive funding up to $306,872 for Phase I and $2,045,816 for Phase II, with a submission deadline of April 5, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PA-24-246.html.
    NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)" aimed at supporting Small Business Concerns (SBCs) in conducting investigator-initiated exploratory clinical trials related to neurological disorders. This initiative encourages applications for Phase I and II studies focusing on drugs, biologics, devices, and therapies that align with the mission of the National Institute of Neurological Disorders and Stroke (NINDS), emphasizing the inclusion of a Plan for Enhancing Diverse Perspectives (PEDP) to foster innovation. The maximum funding amounts are $295,924 for Phase I and $1,972,828 for Phase II projects, with applications required to demonstrate readiness for eventual FDA regulatory approval. Interested applicants can begin submitting proposals on December 5, 2023, with the application deadline set for September 5, 2026; for further inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) to support pre-clinical research aimed at bridging funding gaps that impede the commercialization of medical biotechnology products. This funding opportunity specifically targets previously funded SBIR or STTR Phase II projects, with the objective of advancing products or technologies that require federal regulatory approval, while fostering partnerships between small businesses and external investors to enhance commercialization prospects. Applicants are encouraged to secure independent third-party funding that equals or exceeds one-third of the requested NINDS funds, and must include a Plan for Enhancing Diverse Perspectives (PEDP) to promote inclusivity in the research environment. The application deadline is April 5, 2027, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found in the full announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-222.html.
    SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the SBIR/STTR Commercialization Readiness Pilot (CRP) Program, which aims to support small business concerns (SBCs) in advancing their previously funded SBIR and STTR Phase II and Phase IIB projects towards commercialization. This funding opportunity provides financial assistance for technical support and late-stage research and development activities that are typically not covered by standard Phase II or Phase IIB grants, excluding clinical trials. Eligible applicants must have active Phase II or Phase IIB awards from participating NIH institutes within the last 36 months, with potential funding reaching up to $1,000,000 per year for a maximum of three years. Interested parties should contact NIH Grants Information at grantsinfo@nih.gov for further inquiries, and note that the application deadline is April 5, 2025.
    NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering NINDS Renewal Awards of Small Business Innovation Research (SBIR) Phase II Grants (Phase IIB) to support clinical trials and clinical research projects focused on neurological disorders. This funding opportunity encourages small business concerns (SBCs) to seek additional funding for projects previously funded by NIH SBIR and STTR Phase II awards, with an emphasis on facilitating the transition of these projects to commercialization through partnerships with third-party investors. The initiative aims to address the "Valley of Death" funding gap in medical biotechnology, particularly for products related to the mission of the National Institute of Neurological Disorders and Stroke (NINDS). Interested applicants must submit a Commercialization Plan and a Plan for Enhancing Diverse Perspectives (PEDP), with the application opening on August 5, 2024, and a closing date of April 5, 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Fisheries Resource Monitoring Program (2026-2029)
    Interior Business Center
    The Interior Business Center of the U.S. Department of the Interior is offering a grant opportunity through the Fisheries Resource Monitoring Program (FRMP) for projects aimed at enhancing subsistence fisheries management in Alaska from 2026 to 2029. Eligible applicants, including small businesses, state, local, and tribal governments, and non-profit organizations, are encouraged to submit proposals that align with specific Priority Information Needs identified by Federal Subsistence Regional Advisory Councils, focusing on data collection related to harvest monitoring, traditional ecological knowledge, and stock status. With a total funding pool of $9 million and individual awards ranging from $40,000 to $940,000, proposals must be submitted by May 16, 2025, and will undergo a merit review process emphasizing community involvement and the incorporation of Indigenous knowledge. For further inquiries, applicants can contact Kristen Barth at kristenbarth@ibc.doi.gov.